SOAP Note for Bilateral Lower-Leg Pitting Edema in CHF Patient
For a 65-year-old male with hypertension and chronic heart failure presenting with bilateral lower-leg pitting edema, document volume overload as the primary problem, initiate or uptitrate loop diuretics (at least double the home dose if already on diuretics), and optimize guideline-directed medical therapy including ACE inhibitors/ARBs and beta-blockers.
Subjective Section
Document the following specific elements:
Symptom Characteristics:
- Duration and progression of leg swelling (hours vs. days/weeks)
- Presence of dyspnea (at rest, with exertion, orthopnea, paroxysmal nocturnal dyspnea) 1
- Decreased exercise tolerance or fatigue
- Weight gain pattern (>3-4 lbs in 3-4 days is clinically significant) 1
- Abdominal distention, right upper quadrant discomfort
- Reduced urine output
Medication History:
- Current diuretic dose and compliance
- ACE inhibitor/ARB dose
- Beta-blocker dose
- Recent medication changes
- Use of NSAIDs (contraindicated) 2
Contributing Factors:
- Dietary sodium intake
- Fluid intake patterns
- Recent hospitalizations for heart failure 3
Objective Section
Physical Examination Findings - Document at least 2:
- Peripheral edema: Grade the pitting edema (1-4+) in feet, ankles, legs, presacral area 1
- Jugular venous pressure: Elevated JVP and/or hepatojugular reflux 1
- Pulmonary findings: Bilateral basilar rales/crackles 1
- Cardiac findings: S3 gallop, displaced point of maximal impulse 1
- Weight: Current weight and comparison to baseline/dry weight 1
- Vital signs: Blood pressure (critical for treatment decisions), heart rate, respiratory rate
Laboratory Data (obtain within 24 hours):
- BNP or NT-proBNP (typically >500 pg/mL or >2000 pg/mL respectively in acute decompensation) 1
- Serum creatinine and BUN (baseline renal function)
- Electrolytes (sodium, potassium, chloride)
- Serum albumin (to assess oncotic pressure and nutritional status) 4
Additional Studies:
- Chest X-ray if pulmonary congestion suspected
- Echocardiogram data (ejection fraction, filling pressures if available)
Assessment Section
Primary Diagnosis:
- Acute decompensated heart failure with volume overload (specify HFrEF if EF <40%)
- NYHA functional class (II, III, or IV based on symptoms)
Contributing Factors:
- Chronic heart failure with reduced ejection fraction
- Hypertension (controlled vs. uncontrolled)
- Medication non-adherence vs. inadequate diuretic dosing
- Dietary indiscretion (sodium/fluid intake)
Severity Assessment:
- Hemodynamic profile: "wet and warm" (most common - 70-75% of patients) 4
- Risk stratification based on presentation blood pressure (higher SBP associated with better outcomes) 5
Plan Section
Immediate Management
Diuretic Therapy (Essential for symptomatic relief):
If hospitalized or requiring IV therapy:
- For patients on chronic oral diuretics: Start IV furosemide at at least 2-2.5× the total daily oral dose 4, 6, 7
- Example: If on furosemide 40 mg daily → start 80-100 mg IV
- For diuretic-naive patients: Start furosemide 20-40 mg IV 7
- Administer as intermittent boluses or continuous infusion (both equally effective) 7
- Monitor: Urine output, daily weights, symptoms, renal function, and electrolytes 7
If outpatient management appropriate:
- Increase oral loop diuretic dose
- Consider twice-daily dosing if inadequate response 2
- If GFR <30 mL/min: Use loop diuretics, avoid thiazides except synergistically with loops 2
Adjunctive Diuretic Therapy (if insufficient response):
- Combine loop diuretic with thiazide-type diuretic 2, 7
- Consider adding metolazone in severe cases with frequent creatinine/electrolyte monitoring 2
Guideline-Directed Medical Therapy Optimization
ACE Inhibitors (First-line therapy):
- If not on ACE inhibitor: Initiate at low dose, uptitrate to target doses from major trials 2
- Always combine with diuretics 2
- Monitor BP, renal function, and electrolytes at 1-2 weeks after dose changes, then at 3 months, then every 6 months 2
- Avoid potassium-sparing diuretics during ACE inhibitor initiation 2
Beta-Blockers:
- Continue in stable patients (improves outcomes in HFrEF) 2
- May need temporary dose reduction if hypotensive
Mineralocorticoid Receptor Antagonists:
- Consider adding if hypokalemia persists after ACE inhibitor initiation 2
- Start low dose, check potassium and creatinine after 5-7 days 2
Monitoring Plan
Short-term (during diuresis):
- Daily weights (target 1-2 kg/day fluid loss)
- Urine output monitoring
- Renal function and electrolytes every 2-3 days initially
- Accept modest creatinine increases (up to 50% from baseline) if transient and accompanied by successful decongestion 4
- Target BNP/NT-proBNP reduction of ≥30% before discharge (associated with better outcomes) 4
Decongestion Goals:
- Resolution of orthopnea and dyspnea
- JVP normalization (may need adjustment if right-left heart pressure mismatch) 4
- Elimination of peripheral edema (may need to relax goal if chronic venous insufficiency or low albumin present) 4
- Return to dry weight
Patient Education and Non-Pharmacological Management
Dietary Modifications:
- Sodium restriction (especially in severe heart failure) 2
- Fluid restriction in severe HF 2
- Avoid excessive alcohol 2
Self-Monitoring:
- Daily weights at same time (report gain >3-4 lbs in 3-4 days) 2
- Symptom recognition and when to seek care 2
Activity:
- Maintain daily physical activity in stable patients to prevent deconditioning 2
- Rest not encouraged in stable conditions 2
Follow-up
- Reassess in 1-2 weeks if outpatient management
- Consider hospitalization if: severe symptoms, hypotension, significant renal dysfunction, or inadequate outpatient response
- Long-term follow-up every 3-6 months once stable
Critical Pitfalls to Avoid
- Do not withhold diuretics due to modest creatinine elevation if patient remains congested - transient worsening renal function during effective diuresis is acceptable and associated with better outcomes 4
- Do not use NSAIDs - they antagonize diuretic effects and worsen heart failure 2
- Do not add potassium-sparing diuretics during ACE inhibitor initiation - risk of hyperkalemia 2
- Do not undertitrate diuretics - persistent congestion worsens outcomes more than transient renal dysfunction 4